Marti’s Wish supports faculty researchers pursuing pilot studies of biological mechanisms, including tumor biology and treatment resistance, to advance research relevant to signet ring cell carcinoma.
Funder: Medical University of South Carolina
Due Dates: November 3, 2026 (Applications open) | February 26, 2027 (Application deadline)
Funding Amounts: Up to $50,000 for 12 months
Summary: Supports faculty-led pilot research on biological mechanisms with clear relevance to signet ring cell carcinoma.
Key Information: Studies may examine any cancer type, but must demonstrate clear relevance to signet ring cell carcinoma.
Marti’s Wish is a pilot research award offered by the Medical University of South Carolina through Hollings Cancer Center. It supports studies of biological mechanisms relevant to signet ring cell carcinoma, including metastasis, tumor biology, biomarker development, and treatment resistance. Projects may examine any cancer type when they have clear relevance to signet ring cell carcinoma.
The award is part of Hollings’ intramural support for faculty conducting cancer-related research. These opportunities foster interdisciplinary collaboration, innovative thinking, and translational research. They aim to catalyze promising work aligned with Hollings’ strategic priorities and showing strong potential for future extramural support.